Category: Pharmaceuticals
Pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer have reportedly announced to combine their consumer healthcare businesses into a single entity with annual sales of about USD 12.7 billion. As per …
Florida based biopharma firm Catalyst Pharmaceuticals Inc. has recently announced that it has signed a definitive agreement with Endo Ventures Limited, a subsidiary of Endo International plc (ENDP). Apparently, …
The Pharmaceutical firm received the final approval for its Fluocinolone Acetonide Oil. The ear drops have been suitably developed to treat eczema of the ear. Glenmark Pharmaceuticals (Glenmark), a …
The exclusive licensing agreement is for the development as well as commercialization of a TRK modulator called PBI-100. The company aims to develop the TRK modulator for a plethora …
Taisho Pharmaceutical Holdings Co Ltd, the Japanese healthcare company, is reportedly nearing an agreement to takeover UPSA, the French over-the-counter business of Bristol-Myers Squibb. Sources with knowledge of the …
The Australian health & beauty company has made an A$727 million offer to acquire Sigma Healthcare. The move aims to reinforce API’s position in the market in the wake …
The US-based pharma giant Merck reportedly announced that it has signed a collaboration agreement with Instituto Butantan, a Brazilian non-profit manufacturer of immunobiological products, to develop vaccines which would …
The supply and distribution agreement will provide Aphria’s medical cannabis product throughout Paraguay Canada’s cannabis producer, Aphria Inc. has recently inked a letter of intent to supply medical cannabis to …
IP Group plc., a UK-based intellectual property company, recently announced the agreement between its private equity firm Avacta Group and LG Chem Life Sciences, a subsidiary of South Korean …
Evox Therapeutics, an Oxford-based, privately held biotechnology firm has reportedly announced that it has successfully secured funding from the Bill & Melinda Gates Foundation to help its drug development …
